BƯỚC ĐẦU ĐÁNH GIÁ HIỆU QUẢ VÀ ĐỘ AN TOÀN CỦA EMICIZUMAB TRONG ĐIỀU TRỊ DỰ PHÒNG Ở BỆNH NHI HEMOPHILIA A TẠI BỆNH VIỆN TRUYỀN MÁU HUYẾT HỌC – BÁO CÁO LOẠT 5 CA BỆNH

Objective: To evaluate the efficacy of emicizumab and identify treatment-related adverse events in pediatric patients with hemophilia A.Subjects and methods: A retrospective case-series study was conducted in 5 male pediatric patients diagnosed with hemophilia A (HA) and treated with emicizumab at the Blood Transfusion and Hematology Hospital between February 2022 and February 2024. Treatment efficacy was assessed using the annualized bleeding rate (ABR), annualized joint bleeding rate (AJBR), target joint status, and the Hemophilia Joint Health Score (HJHS). Safety was evaluated through the monitoring of adverse events.Results: Following emicizumab treatment, ABR decreased markedly in all patients, AJBR decreased in all four patients with joint bleeding before treatment, and the post-treatment HJHS was 0 in all patients. Four of the five patients had no adverse events; one patient developed injection-site swelling and itching with fever.Conclusion: Preliminary findings suggest that emicizumab is an effective and safe prophylactic therapy for pediatric patients with HA, reducing bleeding episodes and stabilizing joint status with few adverse effects.

Authors

Publication Details

Journal
Journal of Clinical Medicine Bach Mai Hospital
Published
2026-11-21
DOI
https://doi.org/10.52322/jocmbmh.156.0315
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

BƯỚC ĐẦU ĐÁNH GIÁ HIỆU QUẢ VÀ ĐỘ AN TOÀN CỦA EMICIZUMAB TRONG ĐIỀU TRỊ DỰ PHÒNG Ở BỆNH NHI HEMOPHILIA A TẠI BỆNH VIỆN TRUYỀN MÁU HUYẾT HỌC – BÁO CÁO LOẠT 5 CA BỆNH

Chí Dũng Phù, Văn Tân Ngô, Thảo Nguyên Vương, Thị Hương Giang Nguyễn
Journal of Clinical Medicine Bach Mai Hospital
Hemophilia Treatment and Research
article

BƯỚC ĐẦU ĐÁNH GIÁ HIỆU QUẢ VÀ ĐỘ AN TOÀN CỦA EMICIZUMAB TRONG ĐIỀU TRỊ DỰ PHÒNG Ở BỆNH NHI HEMOPHILIA A TẠI BỆNH VIỆN TRUYỀN MÁU HUYẾT HỌC – BÁO CÁO LOẠT 5 CA BỆNH

Chí Dũng Phù, Văn Tân Ngô, Thảo Nguyên Vương, Thị Hương Giang Nguyễn
article en

Abstract

Objective: To evaluate the efficacy of emicizumab and identify treatment-related adverse events in pediatric patients with hemophilia A.Subjects and methods: A retrospective case-series study was conducted in 5 male pediatric patients diagnosed with hemophilia A (HA) and treated with emicizumab at the Blood Transfusion and Hematology Hospital between February 2022 and February 2024. Treatment efficacy was assessed using the annualized bleeding rate (ABR), annualized joint bleeding rate (AJBR), target joint status, and the Hemophilia Joint Health Score (HJHS). Safety was evaluated through the monitoring of adverse events.Results: Following emicizumab treatment, ABR decreased markedly in all patients, AJBR decreased in all four patients with joint bleeding before treatment, and the post-treatment HJHS was 0 in all patients. Four of the five patients had no adverse events; one patient developed injection-site swelling and itching with fever.Conclusion: Preliminary findings suggest that emicizumab is an effective and safe prophylactic therapy for pediatric patients with HA, reducing bleeding episodes and stabilizing joint status with few adverse effects.

Journal of Clinical Medicine Bach Mai HospitalVol. 3(156)
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
BƯỚC ĐẦU ĐÁNH GIÁ HIỆU QUẢ VÀ ĐỘ AN TOÀN CỦA EMICIZUMAB TRONG ĐIỀU TRỊ DỰ PHÒNG Ở BỆNH NHI HEMOPHILIA A TẠI BỆNH VIỆN TRUYỀN MÁU HUYẾT HỌC – BÁO CÁO LOẠT 5 CA BỆNH — Chí Dũng Phù, Văn Tân Ngô, et al. · Journal of Clinical Medicine Bach Mai Hospital (2026) | TGRS Research Map | TGRS